ADR News Bulletin 2020 May (Volume 22 Number 1)

Bulletin Highlights:

  • MOH’s National Drug Allergy Reporting Guidelines to reduce medication errors     
  • Fimasartan and local reports of liver injury
  • Analysis of adverse event reports for year 2019
  • Safety update on gentian violet antiseptic
  • AE Case in Focus: Test Yourself - What could have caused the development of bullous pemphigoid-like lesions on the patient’s palms and soles and macular pruritic lesions on his body trunk?
  • Risk of adverse outcomes with light-exposed parenteral nutrition products when used in neonates and children below two years old

Click on the link below to download the issue in pdf:

ADR_News_May2020_Vol22_No1658 KB

Healthcare professional, Industry member, Therapeutic Products
Published:

Adverse Drug Reaction News Bulletins

13 May 2020
Doctors, dentists and pharmacists can claim continuing education points for reading each issue of the HSA ADR News Bulletin. Doctors can apply for one non-core Continuing Medical Education (CME) point under category 3A, dentists can apply for one Continuing Professional Education (CPE) point under category 3A and pharmacists can apply for one patient-care Continuing Professional Education (CPE) point under category 3A per issue of the bulletin. Each issue of the bulletin is valid for two years.